Related Experiment Video
Updated: Mar 2, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.4K
Gestational Diabetes: Diagnosis, Classification, and Clinical Care
1Division of Diabetes, Endocrinology, and Metabolism, Department of Internal Medicine, 984120 Nebraska Medical Center, Omaha, NE 68198-4120, USA.
Obstetrics and Gynecology Clinics of North America
|May 14, 2017
Summary
Gestational diabetes mellitus (GDM) affects 6% of pregnancies, with increasing rates linked to obesity. Effective GDM management reduces complications like preeclampsia and macrosomia.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- Gestational diabetes mellitus (GDM) affects approximately 6% of pregnant women.
- Increasing GDM prevalence is associated with the global obesity epidemic.
- Current screening and diagnostic protocols for GDM lack universal consensus.
Purpose of the Study:
- To summarize current understanding and management of GDM.
- To highlight the benefits of GDM treatment on pregnancy outcomes.
- To discuss interventions for women with prediabetes to prevent type 2 diabetes.
Main Methods:
- Review of existing guidelines and treatment protocols for GDM.
- Analysis of the impact of GDM management on maternal and fetal complications.
- Evaluation of interventions for prediabetes in preventing progression to type 2 diabetes.
Main Results:
- GDM treatment significantly reduces the incidence of preeclampsia, shoulder dystocia, and macrosomia.
- When lifestyle modifications are insufficient, pharmacological interventions (metformin, glyburide, insulin) are recommended.
- Pregnancies with GDM are generally advised not to extend beyond term.
- Intensive lifestyle intervention and metformin can prevent or delay type 2 diabetes in women with prediabetes.
Conclusions:
- Effective management of GDM is crucial for improving pregnancy outcomes.
- Pharmacological treatments are indicated when lifestyle changes fail to achieve glycemic targets.
- Early intervention for prediabetes is vital in preventing the development of type 2 diabetes.
More Related Videos
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K
01:20Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
01:15Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
01:15Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K